Taking on the Alzheimer's establishment
Although Alzheimer’s drugs continue to flail and fail, there’s a notable dearth of NIH funding for researchers who take unorthodox approaches to the disease. Take Robert Moir: The Massachusetts General Hospital neurobiologist has long pursued the idea that neurodegenerative disease may have a microbial root — but he’s seen funding requests and papers denied time after time. The beta-amyloid hypothesis reigns supreme, and it’s difficult to get notice if a researcher doesn’t conform.
Here’s how Moir, an unorthodox scientist, bucked the prevailing theory and managed to make a mark.
No hay comentarios:
Publicar un comentario